Discovering The Function And Structure Of RIO Kinases – Toward New Nematocides
Funder
National Health and Medical Research Council
Funding Amount
$545,477.00
Summary
This project is focused on: high quality fundamental molecular science, contributing to national objectives, including the development of novel and innovative scientific concepts and international collaborations; consolidating links between basic and applied research; enhancing the skills-base in molecular biology and global visibility of Australian science.
Resetting The Tipping Point: Converting Immune Checkpoint Non-responders Into Responders.
Funder
National Health and Medical Research Council
Funding Amount
$455,135.00
Summary
Although immunotherapy has recently shown a breakthrough in the treatment of lung cancers, with long-term full regression of the cancer in some patients, most patients unfortunately do not respond. In this proposal, we want to characterise the events that occur in a cancer that is cured by immunotherapy, while it regresses. By subsequently reinforcing those processes, we aim to tip the balance towards a response, thereby increasing the cure rate.
Systems Biology Of Asthma Development In Early Childhood
Funder
National Health and Medical Research Council
Funding Amount
$763,800.00
Summary
Recent studies have established that both human genetic susceptibility and viral infections during early childhood are important drivers of asthma development. It has also been noted that asthmatics’ airways are colonized with different bacteria to non-asthmatics. In this project we will examine how genetic susceptibility and interactions between bacteria and viruses in children's airways promote the development of allergy and asthma.
Unlocking Hidden Cancer Drivers Using Transcriptome Data
Funder
National Health and Medical Research Council
Funding Amount
$700,473.00
Summary
New sequencing technologies allow us to get an unbiased look at the molecular signalling in a tumour. However this information is very complex and need specialised methods in statistic and computation in order to make new discoveries. Here will will develop analysis methods to find novel transcriptional variants in cancer and then test them in the lab in order to understand if our discoveries are responsible for causing cancer.
Integrative Genomics And Prediction Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$766,820.00
Summary
Technologies that measure whole molecular systems are just beginning to reveal the complexity of living organisms and the underlying molecular networks that govern them. Cardiovascular diseases emerge out of these networks as a result of genetic and molecular perturbations. This project aims to characterize the role molecular networks play in cardiovascular disease risk as well as how they react to genetic risk factors. In doing so, it will identify potential therapeutics and personalized approa ....Technologies that measure whole molecular systems are just beginning to reveal the complexity of living organisms and the underlying molecular networks that govern them. Cardiovascular diseases emerge out of these networks as a result of genetic and molecular perturbations. This project aims to characterize the role molecular networks play in cardiovascular disease risk as well as how they react to genetic risk factors. In doing so, it will identify potential therapeutics and personalized approaches to target pathogenesis.Read moreRead less
Identifying Cell Type Specific Biomarkers Of Recurrent Oral Squamous Cell Carcinoma And Mapping Cancer-stroma Interactions Using Single Cell Biology And Cell-to-cell Communication Networks
Funder
National Health and Medical Research Council
Funding Amount
$892,858.00
Summary
Cancer is a major cause of death in Australia. Despite advances in our understanding of the mutations that occur and the sets of genes expressed in cancer we have a major gap in our understanding of what is happening within tumours. Using new single cell technology we will generate new molecular portraits of cancers that give us understanding of the sets of genes expressed on individual cancer cells, the normal cells within a tumour and how they interact with cancer cells to form a tumour.
An Integrated Virtual Cell Approach Towards Elucidating The Systems Pharmacology Of Antibiotics Against Pseudomonas Aeruginosa
Funder
National Health and Medical Research Council
Funding Amount
$823,718.00
Summary
Pseudomonas aeruginosa is a top-priority dangerous ‘superbug’ causing life-threatening infections worldwide. This innovative study will employ a multi-disciplinary approach to model bacterial responses to antibiotic treatments by taking into account all essential components in a cell. This project is of high significance and will shift the paradigm of traditional antimicrobial pharmacology. Importantly, this proposal targets an urgent and critical global health issue: antibiotic resistance.
Systems Genomics Of Childhood Trajectories In Immune Development And Asthma
Funder
National Health and Medical Research Council
Funding Amount
$1,001,092.00
Summary
Infant immune systems start at different competencies and mature at different rates. Little is known about this process and its effect on diseases such as asthma, allergy and respiratory infection. Using a prospective cohort, we aim to dissect the complexity of immune development in early life by characterizing its relationship with genetics, microbial colonization of the airways, and respiratory illness.
Compounded by massive global food and water shortages, neglected tropical disease (NTD) pathogens have a devastating and long-term impact on billions of humans worldwide. Unlocking the fundamental molecular biology of these pathogens, particularly carcinogens, employing a raft of Frontier Technologies, will lead to new ways of controlling NTDs and will have substantial outcomes through the development of new drugs, vaccines and/or diagnostic tests. We will use cutting-edge molecular technologies ....Compounded by massive global food and water shortages, neglected tropical disease (NTD) pathogens have a devastating and long-term impact on billions of humans worldwide. Unlocking the fundamental molecular biology of these pathogens, particularly carcinogens, employing a raft of Frontier Technologies, will lead to new ways of controlling NTDs and will have substantial outcomes through the development of new drugs, vaccines and/or diagnostic tests. We will use cutting-edge molecular technologies to tackle this area head-on.Read moreRead less
Despite aggressive treatment, the survival rate for high-risk neuroblastoma patients is below 50%. We recently found that these poor-outcome neuroblastomas have a defect in a key drug response pathway, called the JNK pathway. Standard-of-care neuroblastoma drugs all require the JNK pathway to kill neuroblastoma cells, although we have now identified alternative drugs that do not require JNK. We now plan to demonstrate the efficacy of these drugs in neuroblastomas with a defective JNK pathway.